668009241	668009241	CD	B-NP	O
|	|	NN	I-NP	O
DLMC	DLMC	NN	I-NP	O
|	|	NN	I-NP	O
88150002	88150002	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
225978	225978	CD	B-NP	O
|	|	CC	I-NP	O
5/3/2002	5/3/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CAD	CAD	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/17/2002	10/17/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/17/2002	6/17/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
FERRON	FERRON	NNP	B-NP	O
,	,	,	O	O
WARD	WARD	NNP	B-NP	O
S	S	NNP	I-NP	O
532-50-83-4	532-50-83-4	CD	I-NP	O
Fay	Fay	NNP	I-NP	O
Berke	Berke	NNP	I-NP	O
Ral	Ral	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
7/14/02	7/14/02	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
NAGODE	NAGODE	NNP	B-NP	O
,	,	,	O	O
LEONARD	LEONARD	NNP	B-NP	O
GLEN	GLEN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NN	B-NP	B-protein
INHALER	INHALER	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
QID	QID	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
sob	sob	NN	I-NP	I-protein
ECASA	ECASA	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ASPIRIN	ASPIRIN	NNP	I-NP	I-protein
ENTERIC	ENTERIC	NNP	I-NP	I-protein
COATED	COATED	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
FOLATE	FOLATE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FOLIC	FOLIC	NNP	I-NP	I-protein
ACID	ACID	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/20/02	10/20/02	CD	B-NP	O
by	by	IN	B-PP	O
GORDILLO	GORDILLO	NNP	B-NP	O
,	,	,	O	O
DALLAS	DALLAS	NNP	B-NP	O
P.	P.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
91946404	91946404	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FUROSEMIDE	FUROSEMIDE	NNP	B-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/20/02	10/20/02	CD	B-NP	O
by	by	IN	B-PP	O
CHICA	CHICA	NNP	B-NP	B-protein
,	,	,	O	O
HUGO	HUGO	NNP	B-NP	O
HERBERT	HERBERT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
EXTENDED	EXTENDED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
31867599	31867599	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FUROSEMIDE	FUROSEMIDE	NNP	B-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/20/02	10/20/02	CD	B-NP	O
by	by	IN	B-PP	O
HARMSEN	HARMSEN	NNP	B-NP	O
,	,	,	O	O
LAUREN	LAUREN	NNP	B-NP	O
JEROLD	JEROLD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
46931076	46931076	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FUROSEMIDE	FUROSEMIDE	NNP	B-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
HYDRALAZINE	HYDRALAZINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

ZOCOR	ZOCOR	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

AMARYL	AMARYL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
GLIMEPIRIDE	GLIMEPIRIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
START	START	NNP	I-NP	O
THE	THE	DT	B-NP	O
NEXT	NEXT	NNP	I-NP	O
DAY	DAY	NNP	I-NP	O
AVAPRO	AVAPRO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IRBESARTAN	IRBESARTAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
SR	SR	NN	I-NP	O
120	120	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QOD	QOD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
Activity	Activity	NN	I-NP	O
-	-	HYPH	O	O
As	As	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
Immediately	Immediately	RB	B-ADVP	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
XTRH	XTRH	NN	B-NP	O
cardiology	cardiology	NN	I-NP	O
appointment	appointment	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
arranged	arrange	VBN	I-VP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
cad	cad	VB	B-VP	O
PRINCIPAL	PRINCIPAL	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CAD	CAD	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
asthma	asthma	NN	I-NP	O
CVA	CVA	NNP	I-NP	O
CAD	CAD	NNP	I-NP	O
Hemorrhagic	Hemorrhagic	NNP	I-NP	O
stroke	stroke	VBD	B-VP	O
s/p	s/p	NN	B-NP	O
CABG	CABG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cardiac	cardiac	JJ	B-ADJP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dm	dm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
d/o	d/o	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
osa	osa	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cardiac	Cardiac	NNP	I-NP	O
Catheterization	Catheterization	NNP	I-NP	O
with	with	IN	B-PP	O
L	L	NN	B-NP	B-protein
PDA	PDA	NN	I-NP	I-protein
stenting	stente	VBG	B-VP	O
BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
65	65	CD	B-NP	O
yo	yo	NN	I-NP	O
male	male	JJ	B-ADJP	O
with	with	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
exertional	exertional	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
9/21/02	9/21/02	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
his	his	PRP$	B-NP	B-DNA
forst	forst	JJS	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
SSCP	SSCP	NN	B-NP	O
while	while	IN	B-SBAR	O
pushing	push	VBG	B-VP	O
a	a	DT	B-NP	O
grocery	grocery	NN	I-NP	O
cart	cart	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
above	above	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
associated	associate	VBN	I-NP	O
n/v	n/v	NN	I-NP	O
or	or	CC	I-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
over	over	IN	B-PP	O
45	45	CD	B-NP	O
minutes	minute	NNS	I-NP	O
with	with	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
.	.	.	O	O

again	again	RB	B-NP	O
experienced	experienced	JJ	I-NP	O
exertional	exertional	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
while	while	IN	B-SBAR	O
walking	walk	VBG	B-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
9/4/02	9/4/02	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
thrid	thrid	NN	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
was	be	VBD	B-VP	O
onthe	onthe	JJ	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
4/2/02	4/2/02	CD	B-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
descended	descend	VBD	B-VP	O
stairs	stair	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
7/10	7/10	CD	B-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
saw	see	VBD	B-VP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
shortly	shortly	RB	B-ADVP	O
there	there	RB	I-ADVP	O
after	after	IN	B-SBAR	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
two	two	CD	B-NP	O
SL	SL	NN	I-NP	B-protein
NTG	NTG	NN	I-NP	I-protein
.	.	.	O	O

EKG	EKG	NN	B-NP	O
at	at	IN	B-PP	O
PCP	PCP	NN	B-NP	O
office	office	NN	I-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
CP	CP	NN	B-NP	B-DNA
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
CABG	CABG	NN	I-NP	B-protein
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
LE	LE	NN	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

EXAM	EXAM	NN	B-NP	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
JVP	JVP	NN	B-NP	B-protein
of	of	IN	B-PP	O
8	8	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
clear	clear	JJ	B-NP	O
chest	chest	NN	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
cardaic	cardaic	JJ	I-NP	O
exam	exam	NN	I-NP	O
and	and	CC	O	O
only	only	RB	B-NP	O
trace	trace	NN	I-NP	O
edema	edema	NN	I-NP	O
in	in	IN	B-PP	O
extremities	extremity	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
femoral	femoral	JJ	I-NP	O
bruits	bruit	NNS	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
dp	dp	NN	I-NP	O
and	and	CC	I-NP	O
pt	pt	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
Pt	Pt	NNP	I-NP	O
.	.	.	O	O

went	go	VBD	B-VP	O
for	for	IN	B-PP	O
left	left	JJ	B-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
on	on	IN	B-PP	O
9/30/02	9/30/02	CD	B-NP	O
which	which	WDT	I-NP	O
revea	revea	NN	I-NP	O
led	lead	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
dominant	dominant	JJ	I-NP	O
system	system	NN	I-NP	O
with	with	IN	B-PP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
distal	distal	JJ	I-NP	O
LCx/LPDA	LCx/LPDA	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
stanted	stante	VBN	I-VP	O
;	;	:	O	O
the	the	DT	B-NP	O
cath	cath	NN	I-NP	O
als	al	NNS	I-NP	O
o	o	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
SVG-LfPDA	SVG-LfPDA	NN	B-NP	O
and	and	CC	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
SVG-marg	SVG-marg	NN	I-NP	O
2and	2and	CD	I-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
prox	prox	NN	I-NP	O
.	.	.	O	O

RCA	RCA	NN	B-NP	B-protein
.	.	.	O	O

PLAN	PLAN	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	I-NP	O
ischemia	ischemia	NN	I-NP	O
-	-	HYPH	I-NP	O
Continue	Continue	JJ	I-NP	O
home	home	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
regimen	regimen	NN	I-NP	O
with	with	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	I-NP	O
avapro	avapro	NN	I-NP	O
and	and	CC	I-NP	O
zocor	zocor	NN	I-NP	O
.	.	.	O	O

B	B	NN	B-NP	O
blocker	blocker	NN	I-NP	O
help	help	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
asthma	asthma	NN	B-NP	O
attack	attack	NN	I-NP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
with	with	IN	B-PP	O
lopressor	lopressor	NN	B-NP	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	O
held	hold	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
on	on	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
.	.	.	O	O

Rate/rhythm	Rate/rhythm	NN	B-NP	O
-	-	HYPH	I-NP	O
telemetry	telemetry	NN	I-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
-	-	HYPH	O	O
No	No	DT	B-NP	O
signs/sx	signs/sx	NN	I-NP	O
.	.	.	O	O

failure	failure	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
-	-	HYPH	I-NP	O
Baseline	Baseline	NNP	I-NP	O
Cr	Cr	NNP	I-NP	O
1.3	1.3	CD	I-NP	O
;	;	:	O	O
will	will	MD	B-VP	O
recieve	recieve	VB	I-VP	O
mucomyst	mucomyst	NN	B-NP	O
for	for	IN	B-PP	O
renal	renal	JJ	B-NP	O
protection	protection	NN	I-NP	O
with	with	IN	B-PP	O
cath	cath	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
-	-	HYPH	I-NP	O
Will	Will	NNP	I-NP	O
place	place	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
RISS	RISS	NN	B-NP	O
and	and	CC	O	O
continue	continue	VB	B-VP	O
on	on	IN	B-PP	O
amaryl	amaryl	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
-	-	HYPH	I-NP	O
Will	Will	NNP	I-NP	O
continue	continue	VBP	B-VP	O
hime	hime	NN	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
for	for	IN	B-PP	O
OSA	OSA	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BARTKUS	BARTKUS	NNP	B-NP	O
,	,	,	O	O
JOSEPH	JOSEPH	NNP	B-NP	O
DESHAWN	DESHAWN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SN01	SN01	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/14/02	7/14/02	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
55	55	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

